These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15065628)

  • 21. Research profile. Is there a link? TZDs and congestive heart failure. Andrew Karter, PhD.
    Kordella T
    Diabetes Forecast; 2004 Jun; 57(6):98-100. PubMed ID: 15195634
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heart failure while taking glitazones--what do we know today?].
    Halbritter R
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
    [No Abstract]   [Full Text] [Related]  

  • 24. Rosiglitazone and the thiazolidinediones: a changing context.
    Kenny C
    Prim Care Diabetes; 2007 Dec; 1(4):185-6. PubMed ID: 18632043
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute pulmonary edema due to rosiglitazone use in a patient with diabetes mellitus.
    Cekmen N; Cesur M; Cetinbas R; Bedel P; Erdemli O
    J Intensive Care Med; 2006; 21(1):47-50. PubMed ID: 16698744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?
    García-Giménez JL; Sanchis-Gomar F; Pallardó FV
    Mov Disord; 2011 Apr; 26(5):769-71. PubMed ID: 21469214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
    De Flines J; Scheen AJ
    Rev Med Suisse; 2007 Aug; 3(122):1876, 1878-83. PubMed ID: 17896661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazolidinediones in heart failure: slippery when wet.
    Khush KK
    J Card Fail; 2008 Aug; 14(6):453-5. PubMed ID: 18672191
    [No Abstract]   [Full Text] [Related]  

  • 29. Thiazolidinediones and fluid retention.
    Kiryluk K; Isom R
    Kidney Int; 2007 Sep; 72(6):762-8. PubMed ID: 17637710
    [No Abstract]   [Full Text] [Related]  

  • 30. Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation.
    Kaul S; Bolger AF; Herrington D; Giugliano RP; Eckel RH; ;
    J Am Coll Cardiol; 2010 Apr; 55(17):1885-94. PubMed ID: 20413044
    [No Abstract]   [Full Text] [Related]  

  • 31. The rosiglitazone decision process at FDA and EMA. What should we learn?
    Pouwels KB; van Grootheest K
    Int J Risk Saf Med; 2012; 24(2):73-80. PubMed ID: 22751189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The edematogenic properties of insulin.
    Kalambokis GN; Tsatsoulis AA; Tsianos EV
    Am J Kidney Dis; 2004 Oct; 44(4):575-90. PubMed ID: 15384008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study.
    Leung AA; Eurich DT; Lamb DA; Majumdar SR; Johnson JA; Blackburn DF; McAlister FA
    J Card Fail; 2009 Mar; 15(2):152-7. PubMed ID: 19254675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazolinediones and heart failure: the potential to precipitate irreversible cardiac dysfunction.
    Iqbal MB; Fisher NG; Lyne JC; McDonagh TA
    Int J Cardiol; 2008 Jan; 123(2):e35-7. PubMed ID: 17320219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone-induced heart failure despite normal left ventricular function.
    Shah M; Kolandaivelu A; Fearon WF
    Am J Med; 2004 Dec; 117(12):973-4. PubMed ID: 15629744
    [No Abstract]   [Full Text] [Related]  

  • 37. Thiazolidinedione associated volume overload and pulmonary hypertension.
    Michaelson J
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):435-8. PubMed ID: 19124440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjudication of serious heart failure in patients from PROactive.
    Rydén L; Thráinsdóttir I; Swedberg K
    Lancet; 2007 Jan; 369(9557):189-90. PubMed ID: 17240282
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
    Idris I; Warren G; Donnelly R
    Arch Intern Med; 2012 Jul; 172(13):1005-11. PubMed ID: 22688528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
    Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
    Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.